Department of Dental Basic Education, Asahi University School of Dentistry, 1851-1 Hozumi, Mizuho, Gifu 501-0296, Japan.
Chem Biol Interact. 2010 Jan 5;183(1):19-24. doi: 10.1016/j.cbi.2009.10.006.
While bupivacaine is more cardiotoxic than other local anesthetics, the mechanistic background for different toxic effects remains unclear. Several cardiotoxic compounds act on lipid bilayers to change the physicochemical properties of membranes. We comparatively studied the interaction of local anesthetics with lipid membranous systems which might be related to their structure-selective cardiotoxicity. Amide local anesthetics (10-300 microM) were reacted with unilamellar vesicles which were prepared with different phospholipids and cholesterol of varying lipid compositions. They were compared on the potencies to modify membrane fluidity by measuring fluorescence polarization. Local anesthetics interacted with liposomal membranes to increase the fluidity. Increasing anionic phospholipids in membranes enhanced the membrane-fluidizing effects of local anesthetics with the potency being cardiolipin>>phosphatidic acid>phosphatidylglycerol>phosphatidylserine. Cardiolipin was most effective on bupivacaine, followed by ropivacaine. Local anesthetics interacted differently with biomimetic membranes consisting of 10mol% cardiolipin, 50mol% other phospholipids and 40mol% cholesterol with the potency being bupivacaine>>ropivacaine>lidocaine>prilocaine, which agreed with the rank order of cardiotoxicity. Bupivacaine significantly fluidized 2.5-12.5mol% cardiolipin-containing membranes at cardiotoxicologically relevant concentrations. Bupivacaine is considered to affect lipid bilayers by interacting electrostatically with negatively charged cardiolipin head groups and hydrophobically with phospholipid acyl chains. The structure-dependent interaction with lipid membranes containing cardiolipin, which is preferentially localized in cardiomyocyte mitochondrial membranes, may be a mechanistic clue to explain the structure-selective cardiotoxicity of local anesthetics.
布比卡因比其他局部麻醉药更具心脏毒性,但不同毒性作用的机制背景尚不清楚。几种心脏毒性化合物作用于脂双层以改变膜的物理化学性质。我们比较研究了局部麻醉剂与可能与其结构选择性心脏毒性相关的脂质膜系统的相互作用。酰胺类局部麻醉剂(10-300μM)与不同磷脂和胆固醇组成的不同脂质组成的单层囊泡反应。通过测量荧光偏振来比较它们改变膜流动性的能力。局部麻醉剂与脂质体膜相互作用以增加其流动性。在膜中增加阴离子磷脂会增强局部麻醉剂的膜增溶作用,其效力为心磷脂>磷脂酸>磷脂酰甘油>磷脂酰丝氨酸。心磷脂对布比卡因最有效,其次是罗哌卡因。局部麻醉剂与由 10mol%心磷脂、50mol%其他磷脂和 40mol%胆固醇组成的仿生膜相互作用不同,其效力为布比卡因>罗哌卡因>利多卡因>普鲁卡因,与心脏毒性顺序一致。布比卡因以心脏毒性相关浓度显著增溶 2.5-12.5mol%含有心磷脂的膜。布比卡因被认为通过与带负电荷的心磷脂头部基团静电相互作用和与磷脂酰基链疏水相互作用来影响脂质双层。与含有心磷脂的脂质膜的结构依赖性相互作用,心磷脂优先定位于心肌细胞线粒体膜中,可能是解释局部麻醉剂结构选择性心脏毒性的机制线索。